Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aethlon Medical (AEMD) Return on Sales (2016 - 2023)

Aethlon Medical filings provide 13 years of Return on Sales readings, the most recent being 0.04% for Q1 2023.

  • On a quarterly basis, Return on Sales rose 284.0% to 0.04% in Q1 2023 year-over-year; TTM through Mar 2023 was 0.21%, a 15.0% increase, with the full-year FY2023 number at 0.21%, up 15.0% from a year prior.
  • Return on Sales hit 0.04% in Q1 2023 for Aethlon Medical, up from 10.07% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.02% in Q4 2019 to a low of 10.07% in Q4 2022.
  • Median Return on Sales over the past 5 years was 0.21% (2019), compared with a mean of 1.3%.
  • Biggest five-year swings in Return on Sales: plummeted -859bps in 2022 and later soared 284bps in 2023.
  • Aethlon Medical's Return on Sales stood at 0.02% in 2019, then crashed by -85bps to 0.04% in 2020, then plummeted by -3674bps to 1.48% in 2021, then tumbled by -582bps to 10.07% in 2022, then surged by 100bps to 0.04% in 2023.
  • The last three reported values for Return on Sales were 0.04% (Q1 2023), 10.07% (Q4 2022), and 4.26% (Q3 2022) per Business Quant data.